4
Changes in Ownership
Roivant Sciences Ltd. Filed Acc 0001140361-25-004951
President & COO sold 435,425 shares at an average $10.47 ($4,561,041)
- President & COO acquired 600,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Venker Eric · President & COO
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-02-12 | Exercise or conversion : show line 1 in the form | +300,000 | $3.85 | $1,155,000 | 1,032,294 | D |
| 2025-02-12 | Sale : show line 2 in the form | −217,384 | $10.53 | $2,289,054 | 732,294 | D |
| 2025-02-13 | Exercise or conversion : show line 3 in the form | +300,000 | $3.85 | $1,155,000 | 1,114,910 | D |
| 2025-02-13 | Sale : show line 4 in the form | −218,041 | $10.42 | $2,271,987 | 896,869 | D |
| Open-market sales · 435,425 sh · avg $10.47 · $4,561,041 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-02-12 | Exercise or conversion : show line 5 in the form Stock Option (Right to Buy) | −300,000 | 11,326,234 | D |
| 2025-02-13 | Exercise or conversion : show line 6 in the form Stock Option (Right to Buy) | −300,000 | 11,026,234 | D |
Loading xslF345X05/form4.xml…